Severe lactic acidosis with euglycemic diabetic ketoacidosis due to metformin overdose.
Kuno H, Fujimaru T, Kadota N, Konishi K, Sekiguchi M, Watanabe K, Ito Y, Nagahama M, Taki F, Hifumi T, Otani N, Nakayama M.
CEN Case Rep. 2023 Nov;12(4):408-412. doi: 10.1007/s13730-023-00783-w. Epub 2023 Mar 19.
Lactic acidosis in diabetic ketoacidosis.
Feenstra RA, Kiewiet MK, Boerma EC, ter Avest E.
BMJ Case Rep. 2014 Mar 20;2014:bcr2014203594. doi: 10.1136/bcr-2014-203594.
Acute Metabolic Complications in Diabetes.
Rewers A.
In: Cowie CC, Casagrande SS, Menke A, Cissell MA, Eberhardt MS, Meigs JB, Gregg EW, Knowler WC, Barrett-Connor E, Becker DJ, Brancati FL, Boyko EJ, Herman WH, Howard BV, Narayan KMV, Rewers M, Fradkin JE, editors. Diabetes in America. 3rd edition. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (US); 2018 Aug. CHAPTER 17.
[Diabetes emergencies].
Scherbaum WA, Scherbaum CR.
Med Klin Intensivmed Notfmed. 2014 May;109(4):279-92; quiz 293-4. doi: 10.1007/s00063-013-0334-z.
Vascular and metabolic effects of metformin added to insulin therapy in patients with type 1 diabetes: A systematic review and meta-analysis.
Liu YS, Chen CN, Chen ZG, Peng Y, Lin XP, Xu LL.
Diabetes Metab Res Rev. 2020 Sep;36(6):e3334. doi: 10.1002/dmrr.3334. Epub 2020 May 26.
Bone calcium changes during diabetic ketoacidosis: a comparison with lactic acidosis due to volume depletion.
Topaloglu AK, Yildizdas D, Yilmaz HL, Mungan NO, Yuksel B, Ozer G.
Bone. 2005 Jul;37(1):122-7. doi: 10.1016/j.bone.2005.03.012.
Evaluation of Characteristics and Outcomes for Patients with Diabetic Ketoacidosis (DKA) With and Without COVID-19 in Elmhurst Queens During Similar Three-Month Periods in 2019 and 2020.
Patel U, Deluxe L, Salama C, Jimenez AR, Whiting A, Lubin C, Tarlin N.
Cureus. 2021 Jul 16;13(7):e16427. doi: 10.7759/cureus.16427. eCollection 2021 Jul.
A Case Report of Glycogenic Hepatopathy.
Brown D, Mead T.
J Educ Teach Emerg Med. 2021 Jul 15;6(3):V1-V3. doi: 10.21980/J8SQ0Z. eCollection 2021 Jul.
[Diabetic emergencies].
Berger W.
Praxis (Bern 1994). 1997 Feb 18;86(8):308-13.
Non-occlusive Mesenteric Ischemia with Diabetic Ketoacidosis and Lactic Acidosis Following the Administration of a Sodium Glucose Co-transporter 2 Inhibitor.
Gocho N, Aoki E, Okada C, Omura K, Hirashima T, Suzuki N, Tanaka H, Omori Y.
Intern Med. 2016;55(13):1755-60. doi: 10.2169/internalmedicine.55.6338. Epub 2016 Jul 1.
